Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$8.21 USD
+0.27 (3.40%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $8.22 +0.01 (0.12%) 7:22 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
EBS 8.21 +0.27(3.40%)
Will EBS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EBS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EBS
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?
Other News for EBS
Emergent BioSolutions (EBS) Lands $29M International Supply Agreement
Emergent BioSolutions (EBS) Lands $29 Million Government Contract
Emergent Biosolutions secures $29M in MCM product orders from international government partner
Emergent BioSolutions secures $29M in MCM product orders
Emergent BioSolutions secures $29M in MCM product orders